Status of the isocitrate dehydrogenase (IDH) gene allows the classification of GBM into three groups, namely IDH wild-type GBM, which represents about 90% of cases, mutated IDH, or not specified GBM (NOS, unevaluated status) [1,2,3,4,5]. Here, IDH1 is linked to glioblastoma.